Minimal-invasive detection method for tumour und cancer diseases
At Saarland University a special features of tumour cells were identified that could constitute a basis for an improved special diagnostic investigation. Antibodies in a blood or serum sample of patient are directed to specific antigens representing tumour markers. Diagnoses in a relatively advanced state of the illnesses is feasible. In addition the method shows a high accuracy, sensitivity and specificity compared to other single marker tests.
Further Information: PDF
Universität des Saarlandes Wissens- und Technologietransfer GmbH PatentVerwertungsAgentur der saarländischen Hochschulen
Phone: +49 (0)681/302-6340
Contact
Dr. Annekathrin Seifert (Dipl.-Chem.), Dipl.-Kfm. Axel Koch (MBA), Dr. Hauke Studier (Dipl.-Phys.)
Media Contact
All latest news from the category: Technology Offerings
Newest articles
New yttrium-hydrogen compounds discovered
Researchers at the University of Bayreuth have made a significant scientific breakthrough by discovering new yttrium-hydrogen compounds having serious implications for the research on high-pressure superconductivity. High-pressure superconductivity refers to…
New AI model detects ninety percent of lymphatic cancer cases
Medical image analysis using AI has developed rapidly in recent years. Now, one of the largest studies to date has been carried out using AI-assisted image analysis of lymphoma, cancer…
UTA preps giant particle detectors for neutrino project
Excavation of caverns part of Fermilab’s Deep Underground Neutrino Experiment. With excavation work complete at the site where four gigantic particle detectors for the international Deep Underground Neutrino Experiment (DUNE) will be…